Revolution Medicines RVMD
NASDAQ RVMD
$178.12 -21.58 (-10.81%)
As of: Nov 5, 2026 · 3:59 PM EST

Revolution Medicines (RVMD) Liabilities and Shareholders Equity (2019 - 2026)

Updated

Analysis

Revolution Medicines (RVMD) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,221.09 Bn 1,194.71 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 656.38 Bn 576.24 Bn 17.30 Bn 197.43 Bn
3 AbbVie 510.79 Bn 478.80 Bn 13.12 Bn 147.68 Bn
4 Merck 363.00 Bn 317.38 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 313.89 Bn 287.12 Bn - -
6 Astrazeneca 290.02 Bn 263.91 Bn 13.26 Bn 119.92 Bn
7 Amgen 249.59 Bn 204.98 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 208.15 Bn 183.26 Bn 6.73 Bn 51.41 Bn
9 Pfizer 170.74 Bn 118.10 Bn 12.56 Bn 205.00 Bn
10 Revolution Medicines 38.00 Bn 28.20 Bn - 4.32 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.32 Bn
Mar 31, 2026 2.25 Bn
Dec 31, 2025 2.35 Bn
Sep 30, 2025 2.25 Bn
Jun 30, 2025 2.43 Bn
Mar 31, 2025 2.37 Bn
Dec 31, 2024 2.56 Bn
Sep 30, 2024 1.76 Bn
Jun 30, 2024 1.81 Bn
Mar 31, 2024 1.91 Bn
Dec 31, 2023 2.06 Bn
Sep 30, 2023 984.23 Mn
Jun 30, 2023 1.07 Bn
Mar 31, 2023 1.07 Bn
Dec 31, 2022 811.93 Mn
Sep 30, 2022 825.91 Mn
Jun 30, 2022 632.80 Mn
Mar 31, 2022 682.77 Mn
Dec 31, 2021 737.99 Mn
Sep 30, 2021 734.98 Mn
API Access

Revolution Medicines Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=RVMD&period=max&api_key=YOUR_API_KEY